Wegovy side effects in men: what the clinical data actually shows

What the trial data tells us about gastrointestinal effects

STEP 1 followed 1,961 adults with obesity or overweight and at least one weight-related condition over 68 weeks. The most frequently reported side effects across the whole cohort were nausea (around 44% of participants on semaglutide), diarrhoea (around 30%), vomiting (around 24%) and constipation (around 24%). The NHS medicines information for semaglutide lists these same effects, alongside indigestion, stomach pain, burping and fatigue, as the commonly reported ones.

For men reading this, the honest picture is that sex-specific breakdowns were not the primary lens of that trial. What we can say is that the mechanism driving these effects (semaglutide slowing gastric emptying and acting on appetite-regulating pathways in the brain) applies to everyone on the medicine. Most men who experience nausea find it peaks in the days after starting or after a dose step, then eases over a week or two as the body acclimates. Eating smaller portions, avoiding high-fat meals and keeping well hydrated all reduce the intensity for many people, and our page on what to expect from the Wegovy 0.5 mg starting dose goes into more detail on early-stage effects. Personal strategies beyond that are best worked through with your prescriber.

Fatigue and headache are also reported by a meaningful minority, particularly in the earlier weeks. Neither is exclusive to men, and both tend to reduce once a stable dose is established. You can read a broader breakdown of the full side-effect spectrum on our Wegovy side effects overview.

Side effects that men sometimes raise specifically

If you've come to this page after reading things online, you're probably not the first man to wonder whether GLP-1 medicines affect testosterone, energy or muscle mass in ways specific to male physiology. It's a reasonable question, and it deserves a straight answer rather than a brush-off.

There is currently no robust clinical evidence that semaglutide directly suppresses testosterone in men. Weight loss itself (by whatever means) can influence hormonal markers, and some research suggests that reducing excess body fat may modestly improve testosterone levels in men with obesity. That is not a guaranteed outcome of Wegovy treatment, and it is not something we would present as a benefit; it is simply context. The more relevant muscle-mass point is that any significant caloric reduction carries a risk of lean-tissue loss alongside fat loss. Maintaining adequate protein intake and including resistance exercise alongside treatment is consistently recommended in clinical guidance, though the personal specifics belong in a conversation with your prescriber or a dietitian.

Hair thinning (telogen effluvium) following rapid weight loss is reported by some people of both sexes and is thought to be a consequence of caloric deficit rather than the medicine itself, which is one reason our guide to side effects from Wegovy covers how to tell treatment effects apart from the effects of weight loss itself. It is usually temporary. Our page on Wegovy side effects in women covers some overlapping questions about this.

When to get medical help without delay

Most side effects from Wegovy are uncomfortable rather than dangerous. A handful are not. The MHRA's Drug Safety Updates for GLP-1 medicines highlight acute pancreatitis as a known, infrequent but serious risk: severe stomach pain that radiates to the back, with or without vomiting, is the warning sign. This requires urgent medical attention, not a wait-and-see approach.

Other situations that warrant prompt contact with a doctor or urgent care include: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a fast heartbeat with dizziness); symptoms of significant dehydration following persistent vomiting or diarrhoea (very dark urine, confusion, muscle cramps); gallbladder-related symptoms such as right-upper-abdominal pain after eating, especially with fever; and any new or worsening low mood, depression or thoughts of self-harm. These are not common — but they are real, and the right response is to seek help rather than to wait for the next scheduled review.

If you are uncertain whether a symptom is Wegovy-related, contact your prescriber directly. nume's aftercare team is available seven days a week. You can also reach our support team with questions between reviews. And if you experience something unexpected with any medicine, the Yellow Card scheme lets you report it to the MHRA, reports from patients carry real weight in ongoing safety monitoring.

Putting the risk picture in context before deciding

Reading a side-effect list can make any medicine sound alarming. The clinical reality for most men who take Wegovy is a period of GI adjustment in the first few weeks, followed by a more settled experience at a maintenance dose, and it is worth knowing that some people find the side-effect profile more manageable than they expected, as our page on experiencing no side effects on Wegovy explores. Serious effects are uncommon and, where they occur, are generally identifiable early if you know what to watch for, which is exactly why clinical follow-up matters.

Wegovy is a prescription-only medicine, and that status exists for good reason. A prescriber's job is not simply to hand over a pen; it is to weigh your individual health picture against what the evidence shows about benefits and risks. Our prescribers go through that assessment with every patient before treatment starts, and again at each repeat. There is no automatic renewal here. If you are weighing up whether the profile makes Wegovy right for you, you can find a fuller picture of the treatment itself on our Wegovy overview, or explore how it compares with other options on the treatment options page. The consultation is free, and suitability (including any concerns about side effects) is exactly what it is designed to discuss.